PREVENTION OF BONE-MINERAL LOSS IN POSTMENOPAUSAL WOMEN BY NORETHISTERONE
- 1 January 1985
- journal article
- research article
- Vol. 66 (6) , 789-792
Abstract
The effect of norethisterone on bone mineral metabolism was examined in 43 postmenopausal women. A significant decline in serum calcium, phosphate, and alkaline phosphatase in urinary calcium/creatinine ratio and in tubular maximum reabsorption of phosphate was demonstrated. There was no alteration in urinary hydroxyproline/creatinine ratio. The bone mineral content measured over two years by single photon absorptiometry was compared in 20 patients receiving norethisterone and a matched control group receiving placebo. There was significant protection against bone loss in the norethisterone group.This publication has 7 references indexed in Scilit:
- Long-term progestogen treatment and bone remodelling in peri-menopausal women: a longitudinal studyMaturitas, 1982
- TREATMENT OF POST MENOPAUSAL OSTEOPOROSIS. A CONTROLLED THERAPEUTIC TRIAL COMPARING OESTROGEN/GESTAGEN, 1,25‐DIHYDROXY‐VITAMIN D3 AND CALCIUMClinical Endocrinology, 1982
- Changes in Physiologically Free Circulating Estradiol and Testosterone during Exposure to Levonorgestrel*Journal of Clinical Endocrinology & Metabolism, 1981
- Oral medroxyprogesterone in the treatment of postmenopausal symptomsJAMA, 1980
- Prevention of early postmenopausal bone loss: controlled 2‐year study in 315 normal femalesEuropean Journal of Clinical Investigation, 1980
- Replacement Estrogens and Endometrial CancerNew England Journal of Medicine, 1979
- Glucocorticoid Receptors and Inhibition of Bone Cell Growth in Primary Culture12Endocrinology, 1977